文献速递生殖医学

第5天囊胚OCT4表达增高可能解释D5较D6囊胚移植临床结局更优

Increased OCT4 expression in Day 5 blastocysts may explain the increased clinical outcomes of D5 versus D6 blastocyst transfers.
PubMed 文献 · Hum Reprod · 2026-01-01

这项回顾性研究纳入774个冻融单囊胚移植周期,比较同等评级D5与D6囊胚的临床结局及细胞谱系标志物。D5组生化妊娠率、临床妊娠率和活产率均显著高于D6组,D6囊胚OCT4阳性细胞比例明显下降,提示OCT4表达差异可能与结局差异相关。

要点

  • D5单囊胚移植组的活产率显著高于D6组(59.5% vs 37.9%)。
  • 同等评级D5与D6囊胚的滋养外胚层、内细胞团及总细胞数无显著差异。
  • D6囊胚OCT4阳性细胞比例较D5降低(64 ± 4% vs 49 ± 5%)。

核心结论

  • D5囊胚的活产率显著高于D6囊胚,可能与D6囊胚固有的OCT4表达降低有关。

研究设计与样本

  • 回顾性研究,纳入2020年3月至2023年2月台北生育中心的774个冻融单囊胚移植周期。
  • 按评级分为高评级(≥BB,n=694)和低评级(<BB,n=80)。
  • 细胞学分析使用同等评级冻融D5囊胚(n=20)、D6囊胚(n=20)及D5培养至D6的囊胚(ExD6,n=17),以免疫荧光检测OCT4和GATA3,DAPI染总细胞,qRT-PCR检测转录本。

主要发现

  • 在单倍体胚胎移植周期中,D5-SBT组生化妊娠率(HCG+)为71.8% vs D6-SBT组52.3%(P < 0.0001)。
  • D5-SBT组临床妊娠率(SAC+)为66.7% vs D6-SBT组47.7%(P = 0.0001)。
  • D5-SBT组活产率为59.5% vs D6-SBT组37.9%(P < 0.0001),D5-SBT组更高。
  • 同等评级D5与D6囊胚的滋养外胚层、内细胞团及总细胞数无显著差异。
  • D6囊胚OCT4阳性细胞比例较D5降低(D5 vs D6:64 ± 4% vs 49 ± 5% 每胚胎)。

局限性

  • 临床评估仅分析整倍体胚胎,未纳入嵌合体胚胎移植病例。
  • 因胚胎染色样本量有限,无法评估其他多能性标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are the clinical pregnancy rates and cell lineage-related markers of equal-grade Day 5 (D5) and Day 6 (D6) embryos the same? SUMMARY ANSWER: High-grade D5 (HG D5) blastocysts have a higher live birth rate than high-grade D6 (HG D6) blastocysts, which could be associated with differences in intrinsic OCT4 expression. WHAT IS KNOWN ALREADY: In IVF cycles, D5 blastocysts are generally considered to be of higher quality and are preferred for embryo transfer over D6 blastocysts. However, the differences between delayed D6 embryos and D5 embryos remain poorly understood. This study aimed to perform an immunofluorescence (IF)-based analysis to evaluate cell content-related differences between same-grade D5 and D6 blastocysts and to assess how these differences may be associated with the clinical pregnancy outcomes following frozen-thawed embryo transfer cycles. STUDY DESIGN, SIZE, DURATION: This retrospective study included 774 frozen-thawed single blastocyst transfer (SBT) cycles at the Taipei Fertility Center from March 2020 to February 2023. All D5 (D5-SBT) and D6 (D6-SBT) frozen-thawed cycles (n = 774) were classified as high grade (≥BB, n = 694) or low grade (<BB, n = 80). PARTICIPANTS/MATERIALS, SETTING, METHODS: For the cell content analyses, IF staining with the pluripotent marker OCT4 was used to determine the cell numbers in the inner cell mass (ICM), and the trophectoderm (TE) marker GATA3 was used to evaluate the TE region. Same-grade frozen-thawed D5 blastocysts (n = 20), D6 blastocysts (n = 20), and D5 blastocysts cultured to D6 (ExD6, n = 17) were used to assess differences in the cell number in the TE and ICM by evaluating OCT4 and GATA3 expression. The total number of cells was visualized using DAPI staining. OCT4 and GATA3 transcripts were analysed with quantitative reverse transcription polymerase chain reaction (qRT-PCR). MAIN RESULTS AND THE ROLE OF CHANCE: For the clinical results, in the single euploid embryo transfer cycle, the overall biochemical pregnancy rate (HCG+, 71.8% vs 52.3%, P < 0.0001), clinical pregnancy rate (SAC+, +66.7% vs 47.7%, P = 0.0001) and live birth rate (59.5% vs 37.9%, P < 0.0001) were significantly higher in the D5-SBT group than in the D6-SBT group. Among HG embryos, the D5-SBT group consistently demonstrated better clinical outcomes. A generalized linear mixed model revealed that the odds ratios were significantly elevated only for D5 embryos but not for other confounders, highlighting the importance of developmental timing. On the other hand, the staining results showed no significant differences in the numbers of TE, ICM, or total cells between the same-grade D5 and D6 blastocysts. However, a notable decrease in OCT4-positive cells was observed in D6 embryos, suggesting a reduction in embryo quality (D5 vs D6: 64 ± 4% vs 49 ± 5% per embryo). ExD6 blastocysts had a significantly increased number of TE cells compared to D6 blastocysts, reflecting greater expansion of the TE population. Gene expression analysis results aligned with these findings, showing a significant decrease in the OCT4/GATA3 ratio in TE cells from D6 embryos compared to D5 embryos. LIMITATIONS, REASONS FOR CAUTION: This study exclusively analysed euploid embryos in clinical assessments, omitting cases of mosaic embryo transfer. Due to the limited sample size for embryo staining, assessment of additional pluripotent markers was not feasible. WIDER IMPLICATION OF THE FINDINGS: Our research demonstrated a significant decrease in the live birth rate with D6 blastocysts compared to D5 blastocysts. The similar proportion of TE cells between D5 and D6 blastocysts suggests that reduced numbers of OCT4-positive cells in D6 blastocysts, rather than TE proliferation, may influence the embryo developmental potential. STUDY FUNDING/COMPETING INTEREST(S): No specific funding was used for this study. W.F.C. is a co-investigator at Taipei Fertility Center and an employee of Taipei Medical Technology Co., Ltd All other authors declare no conflict of interest related to the content of this study. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Lee JH, Chang WF, Tzeng SY, et al. Increased OCT4 expression in Day 5 blastocysts may explain the increased clinical outcomes of D5 versus D6 blastocyst transfers. Hum Reprod. 2026. PMID: 41218150. doi:10.1093/humrep/deaf211

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。